According to more recent reports, the early versions of Covid 19 managed to spare children, but the Delta variant proved to be less discriminating, and it’s also affecting them.
NPR.org notes that health care workers who are on the front lines are addressing another severe issue: there seems to be a surge in the children who are diagnosed with a combination of Covid 19 and respiratory syncytial virus.
The same website mentioned above notes that the pediatric hospitals in Texas and all over the country reported unseasonably early outbreaks of RSV. This is a virus that manifests mostly as a milf illness that has symptoms similar to cold, but it can cause pneumonia and bronchiolitis in very young children.
The condition can be life-threatening for infants and young adults
The CDC reported that it could be life-threatening in infants and young adults.
At the Texas Children’s Hospital in Houston on Thursday, 25 of 45 hospitalized pediatric patients were diagnosed with RSV as well as COVID-19. “A hospitalization rate much higher than for either virus alone,” officials said.

RSV infections reportedly occur in the late fall, winter and early spring, the CDC explains.
“But last year, during all of the COVID-19 outbreaks and all of our social restriction measures, we did not see RSV the way we normally see it,” Dr. Pia Pannaraj, an infectious diseases specialist at Children’s Hospital in Los Angeles told NPR.
More Covid side effects are analyzed
It’s been just revealed that three new conditions reported by a small number of people after vaccination with COVID-19 shots from Pfizer (PFE.N) and Moderna (MRNA.O) are being studied to assess if they may be possible side-effects – this is what Europe’s drugs regulator said not too long ago, as cited by Reuters press agency.
“Erythema multiforme, a form of allergic skin reaction; glomerulonephritis or kidney inflammation; and nephrotic syndrome, a renal disorder characterised by heavy urinary protein losses,” – all these are being studied by the safety committee of the European Medicines Agency (EMA), according to the regulator.
Stay tuned for more relevant news.